NYSE:BXC BlueLinx Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BlueLinx Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $18.14 -0.18 (-0.98 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$17.10Now: $18.14▼$18.4450-Day Range$13.48MA: $18.67▼$21.8452-Week Range$3.60Now: $18.14▼$35.40Volume144,847 shsAverage Volume213,379 shsMarket Capitalization$171.62 millionP/E RatioN/ADividend YieldN/ABeta2.29 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media BlueLinx Holdings Inc., together with its subsidiaries, distributes building and industrial products in the United States. It distributes structural products, including plywood, oriented strand board, rebar and remesh, lumber, spruce, and other wood products primarily used for structural support, walls, and flooring in construction projects; and specialty products comprising engineered wood, moulding, siding, cedar, metal, and insulation products. The company also provides a range of value-added services and solutions to its customers. It serves dealers, industrial manufacturers, manufactured housing producers, and home improvement retailers through a network of distribution centers. BlueLinx Holdings Inc. was founded in 1996 and is headquartered in Marietta, Georgia.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingBlueLinx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $19.00, BlueLinx has a forecasted upside of 4.7% from its current price of $18.14.Amount of Analyst CoverageBlueLinx has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Community Rank Outperform VotesBlueLinx has received 170 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBlueLinx has received 265 “underperform” votes. (Add your “underperform” vote.)Community SentimentBlueLinx has received 60.92% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BlueLinx and other stocks. Vote “Outperform” if you believe BXC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BXC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBlueLinx does not currently pay a dividend.Dividend GrowthBlueLinx does not have a long track record of dividend growth. Previous Next 2.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BlueLinx insiders have bought 7.88% more of their company's stock than they have sold. Specifically, they have bought $489,500.00 in company stock and sold $453,750.00 in company stock.Percentage Held by InsidersOnly 5.43% of the stock of BlueLinx is held by insiders.Percentage Held by Institutions70.33% of the stock of BlueLinx is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for BlueLinx are expected to grow by 205.71% in the coming year, from $0.70 to $2.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BlueLinx is -14.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BlueLinx is -14.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 1.5Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.48 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Lumber, plywood, & millwork Sub-IndustryTrading Companies & Distributors SectorConstruction Current SymbolNYSE:BXC Previous Symbol CUSIP09624H10 CIK1301787 Webwww.bluelinxco.com Phone770-953-7000Debt Debt-to-Equity RatioN/A Current Ratio3.09 Quick Ratio1.51Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio25.91 P/E GrowthN/A Sales & Book Value Annual Sales$2.64 billion Price / Sales0.07 Cash Flow$2.02 per share Price / Cash Flow9.00 Book Value($2.79) per share Price / Book-6.50Profitability EPS (Most Recent Fiscal Year)($1.25) Net Income$-17,660,000.00 Net Margins-0.43% Return on EquityN/A Return on Assets-0.37%Miscellaneous Employees2,200 Outstanding Shares9,461,000Market Cap$171.62 million Next Earnings Date11/3/2020 (Estimated) OptionableOptionable $18.14 -0.18 (-0.98 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive BXC News and Ratings via Email Sign-up to receive the latest news and ratings for BXC and its competitors with MarketBeat's FREE daily newsletter. BlueLinx (NYSE:BXC) Frequently Asked Questions How has BlueLinx's stock been impacted by Coronavirus (COVID-19)? BlueLinx's stock was trading at $5.53 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BXC stock has increased by 228.0% and is now trading at $18.14. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of BlueLinx? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BlueLinx. When is BlueLinx's next earnings date? BlueLinx is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for BlueLinx. How were BlueLinx's earnings last quarter? BlueLinx Holdings Inc. (NYSE:BXC) posted its earnings results on Monday, August, 3rd. The construction company reported $0.71 EPS for the quarter, beating the consensus estimate of ($0.41) by $1.12. The construction company had revenue of $698.78 million for the quarter, compared to the consensus estimate of $619.11 million. View BlueLinx's earnings history. What price target have analysts set for BXC? 1 analysts have issued 12 month target prices for BlueLinx's shares. Their forecasts range from $19.00 to $19.00. On average, they anticipate BlueLinx's stock price to reach $19.00 in the next year. This suggests a possible upside of 4.7% from the stock's current price. View analysts' price targets for BlueLinx. Are investors shorting BlueLinx? BlueLinx saw a decrease in short interest in August. As of August 31st, there was short interest totaling 269,000 shares, a decrease of 19.0% from the August 15th total of 332,100 shares. Based on an average trading volume of 230,500 shares, the short-interest ratio is presently 1.2 days. Approximately 3.0% of the shares of the stock are sold short. View BlueLinx's Short Interest. Who are some of BlueLinx's key competitors? Some companies that are related to BlueLinx include Fastenal (FAST), W W Grainger (GWW), United Rentals (URI), Watsco (WSO), MSC Industrial Direct (MSM), Air Lease (AL), GATX (GATX), WESCO International (WCC), Applied Industrial Technologies (AIT), Beacon Roofing Supply (BECN), Rush Enterprises (RUSHA), Kaman (KAMN), Textainer Group (TGH), H&E Equipment Services (HEES) and MRC Global (MRC). View all competitors. What other stocks do shareholders of BlueLinx own? Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Civeo (CVEO), Maxar Technologies (MAXR), Sorrento Therapeutics (SRNE), Hologic (HOLX) and Inovio Pharmaceuticals (INO). Who are BlueLinx's key executives? BlueLinx's management team includes the following people: Mr. Mitchell B. Lewis, Pres, CEO & Director (Age 57)Ms. Susan C. O'Farrell, Sr. VP, CFO, Treasurer & Principal Accounting Officer (Age 55)Mr. Shyam K. Reddy, Sr. VP & Chief Transformation Officer (Age 44)Mr. Alexander S. Averitt, Chief Operating Officer (Age 42)Mr. Justin B. Heineman, VP, Gen. Counsel & Corp. Sec. (Age 47) What is BlueLinx's stock symbol? BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC." Who are BlueLinx's major shareholders? BlueLinx's stock is owned by many different retail and institutional investors. Top institutional investors include Acuitas Investments LLC (2.11%), Bridgeway Capital Management Inc. (0.52%), Perritt Capital Management Inc. (0.47%), Jane Street Group LLC (0.38%), PDT Partners LLC (0.37%) and State of Wisconsin Investment Board (0.15%). Company insiders that own BlueLinx stock include Alexander S Averitt, Brian J Sasadu, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC, Shyam K Reddy and Susan C O'farrell. View institutional ownership trends for BlueLinx. Which major investors are selling BlueLinx stock? BXC stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc., and Bank of America Corp DE. View insider buying and selling activity for BlueLinx. Which major investors are buying BlueLinx stock? BXC stock was bought by a variety of institutional investors in the last quarter, including Acuitas Investments LLC, Jane Street Group LLC, PDT Partners LLC, Bridgeway Capital Management Inc., State of Wisconsin Investment Board, Goldman Sachs Group Inc., and Captrust Financial Advisors. Company insiders that have bought BlueLinx stock in the last two years include Alexander S Averitt, Brian J Sasadu, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC, Shyam K Reddy, and Susan C O'farrell. View insider buying and selling activity for BlueLinx. How do I buy shares of BlueLinx? Shares of BXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BlueLinx's stock price today? One share of BXC stock can currently be purchased for approximately $18.14. How big of a company is BlueLinx? BlueLinx has a market capitalization of $171.62 million and generates $2.64 billion in revenue each year. The construction company earns $-17,660,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis. BlueLinx employs 2,200 workers across the globe. What is BlueLinx's official website? The official website for BlueLinx is www.bluelinxco.com. How can I contact BlueLinx? BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The construction company can be reached via phone at 770-953-7000 or via email at [email protected] This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
